Restart Life Sciences (XCNQ:HEAL) Total Assets : C$0.27 Mil (As of Sep. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Restart Life Sciences Total Assets?

Restart Life Sciences's Total Assets for the quarter that ended in Sep. 2024 was C$0.27 Mil.

During the past 3 years, the average Total Assets Growth Rate was -82.60% per year. During the past 5 years, the average Total Assets Growth Rate was -56.70% per year. During the past 10 years, the average Total Assets Growth Rate was -6.30% per year.

During the past 13 years, Restart Life Sciences's highest 3-Year average Total Assets Growth Rate was 322.70%. The lowest was -82.60%. And the median was -15.90%.

Total Assets is connected with ROA %. Restart Life Sciences's annualized ROA % for the quarter that ended in Sep. 2024 was 1,260.27%. Total Assets is also linked to Revenue through Asset Turnover. Restart Life Sciences's Asset Turnover for the quarter that ended in Sep. 2024 was 0.00.

Restart Life Sciences Total Assets Historical Data

The historical data trend for Restart Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Total Assets Chart

Restart Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

7.55

6.59

3.05

0.88

0.30

Restart Life Sciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															-	0.05	0.04	0.03	0.27

Restart Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Restart Life Sciences's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	0.041	+	0.255
	=	0.30

Restart Life Sciences's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	-0.586	+	0.852
	=	0.27

Restart Life Sciences (XCNQ:HEAL) Total Assets Explanation

Total Assets is connected with ROA %.

Restart Life Sciences's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	1.84	/	( (0.026	+	0.266)	/ 2 )
	=	1.84	/	0.146
	=	1,260.27 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Restart Life Sciences's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	0	/	( (0.026	+	0.266)	/ 2 )
=	0	/	0.146
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Restart Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Restart Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

NMLSF:USA HN30:Germany

Address

700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6

Website

https://www.restartlife.co

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).

Executives

Derek Lloyd Harry Ivany	10% Security Holder, Director, Senior Officer
Steven Feldman	Director
William Rascan	Director, Senior Officer

Restart Life Sciences Headlines

No Headlines